Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × capivasertib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Leukemia 2 Healthy Participants 2 Endometrial Neoplasms 2 Disease Progression 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Moderate Hepatic Impairment 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Meningioma 1 Lymphoma 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Exanthema 1 Estrogen Receptor Positive Breast Cancer 1 Diarrhea 1 Chondrosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 CCCA Assessed by Ki67 Drop Below <2.7% From Baseline 1

Interventions

Rituximab 47 Cyclophosphamide 47 Lenalidomide 39 fludarabine 24 obinutuzumab 23 Bendamustine Hydrochloride 18 Magnetic Resonance Spectroscopy 17 fludarabine phosphate 15 Vincristine 15 Prednisone 15 Specimen Handling 14 Doxorubicin 14 zanubrutinib 12 Biopsy 12 ibrutinib 11 tazemetostat 10 venetoclax 9 Whole-Body Irradiation 8 pembrolizumab 7 Peripheral Blood Stem Cell Transplantation 7 Etoposide 7 Mycophenolic Acid 6 CT-P10 6 axicabtagene ciloleucel 5 R-CHOP protocol 5 tisagenlecleucel 4 Therapeutics 4 Stem Cell Transplantation 4 Radiotherapy 4 Prednisolone 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡